NasdaqGS:TECHLife Sciences
Will Bio-Techne (TECH) Turn Ella’s EU Clinical Clearance Into A Precision-Medicine Edge?
Bio-Techne recently announced that its Ella benchtop immunoassay platform has received CE-IVD marking and is now available for clinical use across the European Union, enabling faster, standardized biomarker testing with minimal hands-on time.
This certification broadens Ella’s role from research-only applications into regulated clinical workflows, potentially deepening Bio-Techne’s presence in precision medicine and hospital laboratory settings.
We’ll now examine how Ella’s CE-IVD clearance,...